Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$962M |
| 2 |
Cisco
CSCO
|
+$202M |
| 3 |
Amazon
AMZN
|
+$165M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
Pinduoduo
PDD
|
+$131M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$468M |
| 2 |
Merck
MRK
|
+$306M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$305M |
| 4 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$299M |
| 5 |
TRTN
Triton International Limited
TRTN
|
+$282M |
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Financials | 17.12% |
| 3 | Industrials | 12.97% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
3026
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $554K | ﹤0.01% |
35,129
| – | – |
|
|
TSRI
3027
DELISTED
TSR Inc. New
TSRI
| $553K | ﹤0.01% |
61,417
+998
| +2% | +$8.99K |
|
3028
Canadian Solar
CSIQ
$739M
| $552K | ﹤0.01% |
21,028
+1,156
| +6% | +$30.3K |
|
3029
TIM SA
TIMB
$10.1B
| $549K | ﹤0.01% |
29,694
+164
| +0.6% | +$3.03K |
|
3030
Tourmaline Bio
TRML
$1.22B
| $546K | ﹤0.01% |
20,868
-6,409
| -23% | -$168K |
|
3031
Trio-Tech International
TRT
$23M
| $542K | ﹤0.01% |
106,988
+15,447
| +17% | +$78.3K |
|
3032
Perma-Fix Environmental Services
PESI
$185M
| $541K | ﹤0.01% |
68,862
-7,785
| -10% | -$61.2K |
|
3033
AbCellera Biologics
ABCL
$1.27B
| $540K | ﹤0.01% |
94,567
+5,192
| +6% | +$29.6K |
|
3034
iHeartMedia
IHRT
$339M
| $537K | ﹤0.01% |
201,414
-497,639
| -71% | -$1.33M |
|
3035
USCB Financial Holdings
USCB
$351M
| $534K | ﹤0.01% |
43,562
+13,227
| +44% | +$162K |
|
3036
Lindblad Expeditions
LIND
$741M
| $526K | ﹤0.01% |
46,678
+18,769
| +67% | +$211K |
|
3037
Shattuck Labs
STTK
$96.3M
| $526K | ﹤0.01% |
73,667
-2,678
| -4% | -$19.1K |
|
3038
Genasys
GNSS
$93M
| $525K | ﹤0.01% |
258,856
-72,793
| -22% | -$148K |
|
3039
Taylor Devices
TAYD
$147M
| $520K | ﹤0.01% |
23,542
+1,769
| +8% | +$39.1K |
|
3040
BioAtla
BCAB
$41.9M
| $518K | ﹤0.01% |
210,758
-48,461
| -19% | -$119K |
|
3041
Airgain
AIRG
$50.1M
| $514K | ﹤0.01% |
144,384
-7,398
| -5% | -$26.3K |
|
3042
Terns Pharmaceuticals
TERN
$661M
| $506K | ﹤0.01% |
77,825
-10,887
| -12% | -$70.7K |
|
3043
Travere Therapeutics
TVTX
$1.93B
| $503K | ﹤0.01% |
55,979
+27
| +0% | +$243 |
|
3044
Akero Therapeutics
AKRO
$3.57B
| $489K | ﹤0.01% |
20,943
-81,477
| -80% | -$1.9M |
|
|
AY
3045
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $488K | ﹤0.01% |
22,720
-762,597
| -97% | -$16.4M |
|
3046
Woori Financial
WF
$13.2B
| $486K | ﹤0.01% |
16,063
+1,213
| +8% | +$36.7K |
|
3047
Smart Sand
SND
$75.5M
| $485K | ﹤0.01% |
251,430
+134,192
| +114% | +$259K |
|
3048
Nextracker
NXT
$9.52B
| $476K | ﹤0.01% |
10,159
+168
| +2% | +$7.87K |
|
3049
Xoma
XOMA
$444M
| $472K | ﹤0.01% |
25,516
-2,860
| -10% | -$52.9K |
|
3050
Soho House & Co
SHCO
$1.73B
| $471K | ﹤0.01% |
66,095
+20,050
| +44% | +$143K |
|